Senator Investment Group LP Astrazeneca PLC Transaction History

Senator Investment Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $88.9 Million - $107 Million	-1,500,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $13.9 Million - $16.8 Million	-250,000 Reduced 14.29%	1,500,000 $99.5 Million
Q4 2021 Feb 11, 2022	BUY	$54.02 - $63.83 $13.5 Million - $16 Million	250,000 Added 16.67%	1,750,000 $102 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $27.8 Million - $30.4 Million	500,000 Added 50.0%	1,500,000 $90.1 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $42.4 Million - $49 Million	900,000 Added 900.0%	1,000,000 $49.7 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $4.85 Million - $5.8 Million	100,000 New	100,000 $5 Million

1,341

492M

4.99M

3.18M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $226B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

Stay updated on Senator Investment Group LP with notifications on news.